Hamilton Lane Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Hamilton Lane Advisors’s Portfolio VIRX Stock Details VIRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$56.9K	Hold
2022 Q4	$52K	Hold
2022 Q3	$153K	Sell
2022 Q2	$277K	Hold
2022 Q1	$340K	Hold
2021 Q4	$261K	Hold
2021 Q3	$573K	Buy